当前位置:首页 - 行情中心 - 众生药业(002317) - 财务分析 - 现金流量表

众生药业

(002317)

  

流通市值:153.77亿  总市值:171.60亿
流通股本:7.62亿   总股本:8.50亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,011,706,645396,646,112.362,337,760,235.141,780,366,020.16
  收到的税费返还6,536,650.7712,3004,371,232.024,371,232.02
  收到其他与经营活动有关的现金21,785,697.8816,099,713.26154,803,626.53127,460,005.13
  经营活动现金流入小计1,040,028,993.65412,758,125.622,496,935,093.691,912,197,257.31
  购买商品、接受劳务支付的现金248,294,975.85112,284,469.38635,012,970.99493,712,913.42
  支付给职工以及为职工支付的现金134,950,389.680,259,812.61250,077,832.72193,394,535.33
  支付的各项税费98,750,130.6341,210,262.26230,086,240.28174,220,349.83
  支付其他与经营活动有关的现金518,369,234207,618,549.281,043,915,787.66750,409,056.8
  经营活动现金流出小计1,000,364,730.08441,373,093.532,159,092,831.651,611,736,855.38
  经营活动产生的现金流量净额39,664,263.57-28,614,967.91337,842,262.04300,460,401.93
二、投资活动产生的现金流量:
  收回投资收到的现金640,285,491.91310,170,0001,545,872,375.661,071,497,714.26
  取得投资收益收到的现金17,215,050.852,284,581.6646,888,082.7344,524,549.62
  处置固定资产、无形资产和其他长期资产收回的现金净额4,822,079.6938,494898,677.84875,967.84
  收到的其他与投资活动有关的现金37.770319.16307.37
  投资活动现金流入小计662,322,660.22312,493,075.661,593,659,455.391,116,898,539.09
  购建固定资产、无形资产和其他长期资产支付的现金110,987,535.9254,451,808.32228,262,522.85145,546,258.87
  投资支付的现金431,000,000240,000,000980,000,000850,000,000
  支付其他与投资活动有关的现金00728,106.14728,106.14
  投资活动现金流出小计541,987,535.92294,451,808.321,208,990,628.99996,274,365.01
  投资活动产生的现金流量净额120,335,124.318,041,267.34384,668,826.4120,624,174.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金0037,080,68037,080,680
  取得借款收到的现金209,304,342.8848,895,074.79301,890,620.911,000,000
  收到其他与筹资活动有关的现金47,721,225.71199,732.843,897,870.773,657,812.28
  筹资活动现金流入小计257,025,568.5949,094,807.63342,869,171.6841,738,492.28
  偿还债务支付的现金100,000,0000721,955,370721,955,370
  分配股利、利润或偿付利息支付的现金170,311,295.40170,953,595.58170,953,595.58
  支付其他与筹资活动有关的现金522,960,666.45446,652,662.3912,132,023.2311,307,187.84
  筹资活动现金流出小计793,271,961.85446,652,662.39905,040,988.81904,216,153.42
  筹资活动产生的现金流量净额-536,246,393.26-397,557,854.76-562,171,817.13-862,477,661.14
四、汇率变动对现金及现金等价物的影响-5,718.22-1,963.5920,330.75-14,399.8
五、现金及现金等价物净增加额-376,252,723.61-408,133,518.92160,359,602.06-441,407,484.93
  加:期初现金及现金等价物余额1,362,084,5621,362,084,5621,201,724,959.941,201,724,959.94
  期末现金及现金等价物余额985,831,838.39953,951,043.081,362,084,562760,317,475.01
补充资料:
  净利润184,821,629.29--373,963,482.1-
  资产减值准备9,746,361.61-552,343,518.57-
  固定资产和投资性房地产折旧35,925,817.99-73,628,114.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧35,925,817.99-73,628,114.82-
  无形资产摊销23,092,317.93-48,803,812.09-
  长期待摊费用摊销928,188.82-2,599,317.54-
  处置固定资产、无形资产和其他长期资产的损失-171,158.15--28,462.2-
  固定资产报废损失418,350.38-4,774,970.15-
  公允价值变动损失6,347,793.14-18,219,305.06-
  财务费用2,213,911.58-24,466,673.5-
  投资损失-9,921,614.62--24,869,018.33-
  递延所得税86,491.64-3,156,662.97-
  其中:递延所得税资产减少4,100,240.93-12,759,206.1-
    递延所得税负债增加-4,013,749.29--9,602,543.13-
  存货的减少76,963,014.14-24,188,551.42-
  经营性应收项目的减少-261,630,555.09--348,135,839.76-
  经营性应付项目的增加-71,817,313.94-314,513,666.11-
  其他41,443,122.44-15,824,963.5-
  债务转为资本0-0-
  一年内到期的可转换公司债券0-0-
  融资租入固定资产0-0-
  现金的期末余额985,831,838.39-1,362,084,562-
  减:现金的期初余额1,362,084,562-1,201,724,959.94-
  加:现金等价物的期末余额0-0-
  减:现金等价物的期初余额0-0-
  现金及现金等价物的净增加额-376,252,723.61-160,359,602.06-
公告日期2025-08-292025-04-262025-04-262024-10-29
审计意见(境内)标准无保留意见
TOP↑